NxStage Medical, Inc. 4
4 · NxStage Medical, Inc. · Filed Mar 6, 2017
Insider Transaction Report
Form 4
Brown Robert S.
Sr. Vice President, CFO
Transactions
- Exercise/Conversion
Common Stock
2017-03-03+9,747→ 27,062 total - Tax Payment
Common Stock
2017-03-03$28.31/sh−4,586$129,830→ 22,476 total - Sale
Common Stock
2017-03-06$28.01/sh−6,390$178,984→ 16,086 total - Exercise/Conversion
Restricted Stock Unit
2017-03-03−9,747→ 0 totalExercise: $0.00From: 2015-03-03Exp: 2017-03-03→ Common Stock (9,747 underlying)
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2016.